razoxane has been researched along with Adenocarcinoma in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (95.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Chen, L; He, L; Li, H; Li, L; Li, Y; Liu, M; Lu, Q; Lv, D; Wu, D; Xie, F | 1 |
| Byfield, JE; Clamon, GH; Corder, MP; Herbst, KD; Leimert, JT; Platz, CE; Tewfik, HH | 1 |
| Ashford, RF; Bakowski, M; Evans, M; Hellman, K; Jones, R; Lambert, J; Newton, K; Peters, N; Phillips, R; Smith, BJ | 1 |
| Engstrom, PF; Klaassen, DJ; MacIntyre, JM; Mittelman, A | 1 |
| Blessing, JA; Conroy, JF; Homesley, HD; Kessinger, A | 1 |
| Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M | 1 |
| Bruckner, HW; Lokich, JJ; Stablein, DM | 1 |
| Bunn, PA; Cohen, MH; Eddy, J; Ihde, DC; Krasnow, S; Matthews, MJ; Minna, JD | 1 |
| Burleson, GR; Luckert, PH; Pollard, M | 1 |
| Sherlock, D; Ward, A | 1 |
| Brugarolas, A; Buesa, JM; Gracia Marco, M; Lacave, AJ; Valle Pereda, M | 1 |
| Marchant, J | 1 |
| Hassenstein, E; Rhomberg, W | 1 |
| Goldman, HD; Lee, HJ; Witiak, DT; Zwilling, BS | 1 |
| He, SQ; Li, CF; Liu, TF; Zhen, XY; Zhou, J | 1 |
| Birch, R; Brubaker, LH; Einhorn, LH; Vogel, CL | 1 |
| Bartolucci, A; DeSimone, PA; Greco, FA; Omura, GA | 1 |
| Berman, M; Blessing, JA; Homesley, HD | 1 |
| Blessing, JA; Conroy, J; DiSaia, PJ; Hatch, K; Homesley, HD; Twiggs, LB | 1 |
5 trial(s) available for razoxane and Adenocarcinoma
| Article | Year |
|---|---|
Radiotherapy plus razoxane for advanced limited extent carcinoma of the lung.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Blood Cell Count; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Piperazines; Pneumonia; Radiation Injuries; Random Allocation; Razoxane | 1984 |
A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract.
Topics: Adenocarcinoma; Clinical Trials as Topic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Fluorouracil; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Piperazines; Prognosis; Razoxane; Rectal Neoplasms; Stomach Neoplasms | 1983 |
Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydroxyurea; Male; Middle Aged; Mitomycins; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Time Factors | 1984 |
[Combined treatment of lung carcinoma. Report on a prospective randomized study with radiotherapy and ICRF 159 (1,2-(3,5-dioxopiperazines-lyl)propane) (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Female; Hematologic Diseases; Humans; Male; Middle Aged; Piperazines; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Razoxane | 1977 |
Treatment of advanced adenocarcinoma of the kidney with ICRF-187: a Southeastern Cancer Study Group Trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Piperazines; Razoxane; Stereoisomerism | 1986 |
15 other study(ies) available for razoxane and Adenocarcinoma
| Article | Year |
|---|---|
PAK1-cofilin phosphorylation mediates human lung adenocarcinoma cells migration induced by apelin-13.
Topics: Actin Depolymerizing Factors; Adenocarcinoma; Adenocarcinoma of Lung; Apelin Receptors; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; p21-Activated Kinases; Phosphorylation; Razoxane; Receptors, G-Protein-Coupled; Signal Transduction; Time Factors | 2016 |
Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperazines; Razoxane; Thrombocytopenia | 1984 |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines | 1982 |
Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
Topics: Adenocarcinoma; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Humans; Male; Methotrexate; Middle Aged; Myeloproliferative Disorders; Prognosis; Random Allocation; Razoxane; Triazines | 1982 |
ICRF-159 in advanced gastric cancer. Absence of activity.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Piperazines; Razoxane; Stomach Neoplasms | 1982 |
Interference with in vivo growth and metastasis of prostate adenocarcinoma (PA-III) by ICRF-159.
Topics: Adenocarcinoma; Animals; Cell Division; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasms, Experimental; Piperazines; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Razoxane | 1981 |
Long term survival following chemotherapy for carcinoma of the pancreas.
Topics: Adenocarcinoma; Adult; Female; Fluorouracil; Humans; Pancreatic Neoplasms; Razoxane | 1980 |
Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive origin.
Topics: Adenocarcinoma; Adult; Aged; Ancitabine; Bone Marrow; Cytarabine; Digestive System Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous | 1978 |
Prophylactic chemotherapy following breast cancer: a personal experience.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Female; Humans; Levodopa; Neoplasm Metastasis; Razoxane; Tamoxifen | 1977 |
Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma.
Topics: Adenocarcinoma; Animals; Cricetinae; Lung Neoplasms; Male; Mesocricetus; Molecular Conformation; Neoplasm Metastasis; Neoplasms, Experimental; Piperazines; Razoxane; Structure-Activity Relationship | 1978 |
Radiation survival properties of cultured human gastric adenocarcinoma cells and the effect of AT-1727.
Topics: Adenocarcinoma; Cell Survival; DNA Repair; Humans; In Vitro Techniques; Piperazines; Radiation-Sensitizing Agents; Razoxane; Stomach Neoplasms; Tumor Cells, Cultured | 1989 |
Phase I-II evaluation of razoxane (ICRF-159) and doxorubicin in gastrointestinal cancer. A Southeastern Cancer Study Group Trial.
Topics: Adenocarcinoma; Agranulocytosis; Drug Evaluation; Gastrointestinal Neoplasms; Humans; Piperazines; Razoxane | 1986 |
ICRF-159 (razoxane) in patients with advanced nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Female; Humans; Middle Aged; Piperazines; Razoxane; Uterine Cervical Neoplasms | 1986 |
Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Agents; Deoxyguanosine; Dianhydrogalactitol; Drug Evaluation; Humans; Leukopenia; Pancreatic Neoplasms; Piperazines; Razoxane; Sugar Alcohols; Thionucleosides; Thrombocytopenia; Triazines | 1985 |
ICRF-159 (razoxane) in patients with advanced adenocarcinoma of the endometrium. A Gynecologic Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Female; Humans; Middle Aged; Piperazines; Razoxane; Uterine Neoplasms | 1986 |